24 results
8-K/A
EX-3.1
EFTR
eFFECTOR Therapeutics Inc
9 May 24
Entry into a Material Definitive Agreement
4:34pm
public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
(ll)Cybersecurity. (i
8-K
EX-3.1
EFTR
eFFECTOR Therapeutics Inc
9 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
(ll)Cybersecurity. (i
POS AM
EFTR
eFFECTOR Therapeutics Inc
29 Mar 24
Prospectus update (post-effective amendment)
2:51pm
technology system failures, cyberattacks or deficiencies in our cybersecurity.
In the ordinary course of business, we collect, store, transmit … and collaborators are vulnerable to attack, damage, and interruption from computer viruses, cybersecurity threats (such as denial-of-service attacks, ransomware
8-K
EX-10.1
EFTR
eFFECTOR Therapeutics Inc
26 Jan 24
Offering Priced At-The-Market Under Nasdaq Rules
4:40pm
or their financial results or prospects.
(jj) Cybersecurity. (i)(x) There has been no security breach or other compromise of or relating to any
424B3
xe1r60
8 Jun 23
Prospectus supplement
6:14am
8-K
EX-10.1
op0ymzc6uqq sdndkfq
8 Jun 23
Entry into a Material Definitive Agreement
6:11am
424B3
as6ui0p6
30 May 23
Prospectus supplement
4:29pm
8-K
EX-10.1
b58m6uwrpcwsg25ffd3g
30 May 23
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-1.2
mjzcm4 ukwu
1 Sep 22
Shelf registration
4:02pm
POS AM
r1nmd9
17 Mar 22
Prospectus update (post-effective amendment)
7:18pm
POS AM
67gyxxg5pp 2u2ueez
17 Mar 22
Prospectus update (post-effective amendment)
7:11pm
424B3
jo5q99cv0h7srao av
2 Feb 22
Prospectus supplement
4:52pm
424B3
wm5qael 7ty
5 Oct 21
Prospectus supplement
4:24pm
424B3
ykyxc8zf7n6eurq0
10 Aug 21
Prospectus supplement
5:11pm